(Q39512148)

English

Complete protection against P. berghei malaria upon heterologous prime/boost immunization against circumsporozoite protein employing Salmonella type III secretion system and Bordetella adenylate cyclase toxoid

scientific article published on 17 September 2008

In more languages

Statements

scholarly article

1 reference

Europe PubMed Central

PubMed publication ID

12 September 2017

Complete protection against P. berghei malaria upon heterologous prime/boost immunization against circumsporozoite protein employing Salmonella type III secretion system and Bordetella adenylate cyclase toxoid (English)

1 reference

Europe PubMed Central

PubMed publication ID

12 September 2017

0 references

0 references

object named as

Jana Kamanova

3

0 references

object named as

Peter Sebo

4

0 references

author name string

Susanne Tartz

1

1 reference

Europe PubMed Central

PubMed publication ID

12 September 2017

Holger Rüssmann

2

1 reference

Europe PubMed Central

PubMed publication ID

12 September 2017

Angelika Sturm

5

1 reference

Europe PubMed Central

PubMed publication ID

12 September 2017

Volker Heussler

6

1 reference

Europe PubMed Central

PubMed publication ID

12 September 2017

Bernhard Fleischer

7

1 reference

Europe PubMed Central

PubMed publication ID

12 September 2017

Thomas Jacobs

8

1 reference

Europe PubMed Central

PubMed publication ID

12 September 2017

language of work or name

0 references

publication date

17 September 2008

1 reference

Europe PubMed Central

PubMed publication ID

12 September 2017

1 reference

Europe PubMed Central

PubMed publication ID

12 September 2017

26

1 reference

Europe PubMed Central

PubMed publication ID

12 September 2017

47

1 reference

Europe PubMed Central

PubMed publication ID

12 September 2017

5935-5943

1 reference

Europe PubMed Central

PubMed publication ID

12 September 2017

Protective Immunity produced by the Injection of X-irradiated Sporozoites of Plasmodium berghei

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2008.08.057

7 January 2021

Gamma interferon, CD8+ T cells and antibodies required for immunity to malaria sporozoites

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2008.08.057

7 January 2021

Genetically modified Plasmodium parasites as a protective experimental malaria vaccine

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2008.08.057

7 January 2021

Cloned cytotoxic T cells recognize an epitope in the circumsporozoite protein and protect against malaria

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2008.08.057

7 January 2021

Enhanced immunogenicity for CD8+ T cell induction and complete protective efficacy of malaria DNA vaccination by boosting with modified vaccinia virus Ankara

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2008.08.057

7 January 2021

Oral Salmonella typhimurium vaccine expressing circumsporozoite protein protects against malaria

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2008.08.057

7 January 2021

Oral Salmonella: malaria circumsporozoite recombinants induce specific CD8+ cytotoxic T cells

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2008.08.057

7 January 2021

Generation of a cytotoxic T-lymphocyte response using a Salmonella antigen-delivery system

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2008.08.057

7 January 2021

Enhanced immunity to Plasmodium falciparum circumsporozoite protein (PfCSP) by using Salmonella enterica serovar Typhi expressing PfCSP and a PfCSP-encoding DNA vaccine in a heterologous prime-boost strategy

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2008.08.057

7 January 2021

Delivery of epitopes by the Salmonella type III secretion system for vaccine development

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2008.08.057

7 January 2021

Bacterial type III translocation: a unique mechanism for cytosolic display of heterologous antigens by attenuated Salmonella

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2008.08.057

7 January 2021

Salmonella interactions with host cells: type III secretion at work

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2008.08.057

7 January 2021

Protection against murine listeriosis by oral vaccination with recombinant Salmonella expressing hybrid Yersinia type III proteins.

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2008.08.057

7 January 2021

Salmonella type III-mediated heterologous antigen delivery: a versatile oral vaccination strategy to induce cellular immunity against infectious agents and tumors.

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2008.08.057

7 January 2021

Oral vaccination with recombinant Yersinia enterocolitica expressing hybrid type III proteins protects gerbils from amebic liver abscess

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2008.08.057

7 January 2021

Antigen targeting to CD11b allows efficient presentation of CD4+ and CD8+ T cell epitopes and in vivo Th1-polarized T cell priming

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2008.08.057

7 January 2021

Delivery of CD8(+) T-cell epitopes into major histocompatibility complex class I antigen presentation pathway by Bordetella pertussis adenylate cyclase: delineation of cell invasive structures and permissive insertion sites

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2008.08.057

7 January 2021

Prime/boost immunotherapy of HPV16-induced tumors with E7 protein delivered by Bordetella adenylate cyclase and modified vaccinia virus Ankara

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2008.08.057

7 January 2021

The adenylate cyclase toxin from Bordetella pertussis--a novel promising vehicle for antigen delivery to dendritic cells

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2008.08.057

7 January 2021

Immunization with a circumsporozoite epitope fused to Bordetella pertussis adenylate cyclase in conjunction with cytotoxic T-lymphocyte-associated antigen 4 blockade confers protection against Plasmodium berghei liver-stage malaria

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2008.08.057

7 January 2021

The adenovirus E4-6/7 protein transactivates the E2 promoter by inducing dimerization of a heteromeric E2F complex

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2008.08.057

7 January 2021

A secreted protein tyrosine phosphatase with modular effector domains in the bacterial pathogen Salmonella typhimurium

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2008.08.057

7 January 2021

Aromatic-dependent Salmonella typhimurium are non-virulent and effective as live vaccines

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2008.08.057

7 January 2021

The invasion-associated type-III protein secretion system in Salmonella--a review

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2008.08.057

7 January 2021

Purification of his-tagged proteins by immobilized chelate affinity chromatography: the benefits from the use of organic solvent

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2008.08.057

7 January 2021

CTLA-4-dependent mechanisms prevent T cell induced-liver pathology during the erythrocyte stage of Plasmodium berghei malaria

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2008.08.057

7 January 2021

Identification of the YopE and YopH domains required for secretion and internalization into the cytosol of macrophages, using the cyaA gene fusion approach

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2008.08.057

7 January 2021

The Salmonella typhimurium invasion genes invF and invG encode homologues of the AraC and PulD family of proteins

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2008.08.057

7 January 2021

Rapid clearance of a recombinant Salmonella vaccine carrier prevents enhanced antigen-specific CD8 T-cell responses after oral boost immunizations

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2008.08.057

7 January 2021

Sporozoite vaccine induces genetically restricted T cell elimination of malaria from hepatocytes

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2008.08.057

7 January 2021

Enhanced CD8 T cell immunogenicity and protective efficacy in a mouse malaria model using a recombinant adenoviral vaccine in heterologous prime-boost immunisation regimes

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2008.08.057

7 January 2021

Enhanced CD8+ T cell immune responses and protection elicited against Plasmodium berghei malaria by prime boost immunization regimens using a novel attenuated fowlpox virus

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2008.08.057

7 January 2021

Alternating vector immunizations encoding pre-erythrocytic malaria antigens enhance memory responses in a malaria endemic area

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2008.08.057

7 January 2021

A clinical trial of prime-boost immunisation with the candidate malaria vaccines RTS,S/AS02A and MVA-CS.

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2008.08.057

7 January 2021

A phase 2b randomised trial of the candidate malaria vaccines FP9 ME-TRAP and MVA ME-TRAP among children in Kenya

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2008.08.057

7 January 2021

Enhanced T cell-mediated protection against malaria in human challenges by using the recombinant poxviruses FP9 and modified vaccinia virus Ankara

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2008.08.057

7 January 2021

Delivery of multiple epitopes by recombinant detoxified adenylate cyclase of Bordetella pertussis induces protective antiviral immunity

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2008.08.057

7 January 2021

Interaction of Bordetella pertussis adenylate cyclase with CD11b/CD18: Role of toxin acylation and identification of the main integrin interaction domain

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2008.08.057

7 January 2021

Induction of a polarized Th1 response by insertion of multiple copies of a viral T-cell epitope into adenylate cyclase of Bordetella pertussis

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2008.08.057

7 January 2021

Durable human memory T cells quantifiable by cultured enzyme-linked immunospot assays are induced by heterologous prime boost immunization and correlate with protection against malaria

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2008.08.057

7 January 2021

A CD4(+) T-cell immune response to a conserved epitope in the circumsporozoite protein correlates with protection from natural Plasmodium falciparum infection and disease

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2008.08.057

7 January 2021

Correlation of memory T cell responses against TRAP with protection from clinical malaria, and CD4 CD25 high T cells with susceptibility in Kenyans

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2008.08.057

7 January 2021

Single-dose immunogenicity and protective efficacy of simian adenoviral vectors against Plasmodium berghei

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2008.08.057

7 January 2021

Invariant Valpha14 chain NKT cells promote Plasmodium berghei circumsporozoite protein-specific gamma interferon- and tumor necrosis factor alpha-producing CD8+ T cells in the liver after poxvirus vaccination of mice

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2008.08.057

7 January 2021

Identifiers

10.1016/J.VACCINE.2008.08.057

1 reference

Europe PubMed Central

PubMed publication ID

12 September 2017

release_ixsihsic25g7nk3f4wovcagpsa

0 references

PubMed publication ID

1 reference

Europe PubMed Central

PubMed publication ID

12 September 2017

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q39512148&oldid=1833824862"